Faculty Profiles - ANDO, Masahiko

Papers - ANDO, Masahiko

Division display 121 - 140 of about 369 ／ All the affair displays >>

The relationship between quality of life, adverse events, and treatment efficacy in treatment with first-line chemotherapy plus cetuximab for unresectable metastatic colorectal cancer: Results of phase II QUACK trial

Akira, O; Morita, S; Iwamoto, S; Hara, H; Tanioka, H; Satake, H; Kataoka, M; Tsuji, A; Ando, M; Sakamoto, J; Yamaguchi, K

ANNALS OF ONCOLOGY Vol. 31 page： S90 - S90 2020.7

Phase 2 Trial of Adjuvant Chemotherapy With S-1 for Node-Positive Biliary Tract Cancer (N-SOG 09)

Seita, K; Ebata, T; Mizuno, T; Maeda, A; Yamaguchi, R; Kurumiya, Y; Sakamoto, E; Hiramatsu, K; Ando, M; Nagino, M

ANNALS OF SURGICAL ONCOLOGY Vol. 27 ( 7 ) page： 2348 - 2356 2020.7

Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II trial by the West Japan Oncology Group

Hirata, K; Hamamoto, Y; Ando, M; Imamura, CK; Yoshimura, K; Yamazaki, K; Hironaka, S; Muro, K

BMC CANCER Vol. 20 ( 1 ) page： 548 2020.6

Validation and factor structure of the Japanese version of the inventory to diagnose depression, lifetime version for pregnant women

Kubota, C; Inada, T; Nakamura, Y; Shiino, T; Ando, M; Aleksic, B; Yamauchi, A; Morikawa, M; Okada, T; Ohara, M; Sato, M; Murase, S; Goto, S; Kanai, A; Ozaki, N

PLOS ONE Vol. 15 ( 6 ) page： e0234240 2020.6

PREDICTORS OF DISEASE FLARE AFTER DISCONTINUATION OF CONCOMITANT METHOTREXATE IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOCILIZUMAB

Asai, S; Takahashi, N; Kuwatsuka, Y; Ando, M; Ishiguro, N; Kojima, T

ANNALS OF THE RHEUMATIC DISEASES Vol. 79 page： 252 - 253 2020.6

PREDICT1: An observational study for identifying blood biomarkers associated with clinical benefit from carboplatin and pemetrexed (CbP) treatment in patients with non-squamous (NS) non-small cell lung cancer (NSCLC) (CJLSG1201).

Hase, T; Yanagisawa, K; Fukatsu, A; Kimura, T; Kojima, E; Abe, T; Imaizumi, K; Horio, Y; Oguri, T; Yamamoto, M; Ogasawara, T; Sugino, Y; Morise, M; Nakatochi, M; Ando, M; Kondo, M; Saka, H; Saito, H; Hasegawa, Y; Takahashi, T

JOURNAL OF CLINICAL ONCOLOGY Vol. 38 ( 15 ) 2020.5

The impact of estrogen receptor status on EGFR/TP53/CTNNB1 axis in the evolution of non-small cell lung cancer.

Tani, Y; Koh, Y; Tamiya, A; Isa, S; Kubo, A; Ando, M; Saka, H; Izumi, M; Ogawa, K; Matsumoto, Y; Sawa, K; Yoshimoto, N; Suzumura, T; Watanabe, T; Kaneda, H; Mitsuoka, S; Asai, K; Kawaguchi, T

JOURNAL OF CLINICAL ONCOLOGY Vol. 38 ( 15 ) 2020.5

Fujiya, K; Ando, M; Mizusawa, J; Katai, H; Yamada, T; Ito, S; Fukagawa, T; Bando, E; Misawa, K; Tanizawa, Y; Morita, S; Katayama, H; Yoshikawa, T; Terashima, M; Sasako, M

JOURNAL OF CLINICAL ONCOLOGY Vol. 38 ( 15 ) 2020.5

The Risk Factors Predicting Suicidal Ideation Among Perinatal Women in Japan

Kubota, C; Inada, T; Shiino, T; Ando, M; Sato, M; Nakamura, Y; Yamauchi, A; Morikawa, M; Okada, T; Ohara, M; Aleksic, B; Murase, S; Goto, S; Kanai, A; Ozaki, N

FRONTIERS IN PSYCHIATRY Vol. 11 page： 441 2020.5

Discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab: An interventional study

Asai, S; Hayashi, M; Hanabayashi, M; Kanayama, Y; Takemoto, T; Yabe, Y; Shioura, T; Ishikawa, H; Yoshioka, Y; Kato, T; Hirano, Y; Fujibayashi, T; Hattori, Y; Kobayakawa, T; Ando, M; Kuwatsuka, Y; Takahashi, N; Matsumoto, T; Asai, N; Sobue, Y; Nishiume, T; Suzuki, M; Ishiguro, N; Kojima, T

MODERN RHEUMATOLOGY Vol. 30 ( 3 ) page： 434 - 441 2020.5

Comparison of Carboplatin Plus Pemetrexed Followed by Maintenance Pemetrexed With Docetaxel Monotherapy in Elderly Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer A Phase 3 Randomized Clinical Trial

Okamoto, I; Nokihara, H; Nomura, S; Niho, S; Sugawara, S; Horinouchi, H; Azuma, K; Yoneshima, Y; Murakami, H; Hosomi, Y; Atagi, S; Ozaki, T; Horiike, A; Fujita, Y; Okamoto, H; Ando, M; Yamamoto, N; Ohe, Y; Nakagawa, K

JAMA ONCOLOGY Vol. 6 ( 5 ) 2020.5

Acute exacerbations of fibrotic interstitial lung diseases

Suzuki, A; Kondoh, Y; Brown, KK; Johkoh, T; Kataoka, K; Fukuoka, J; Kimura, T; Matsuda, T; Yokoyama, T; Fukihara, J; Ando, M; Tanaka, T; Hashimoto, N; Sakamoto, K; Hasegawa, Y

RESPIROLOGY Vol. 25 ( 5 ) page： 525 - 534 2020.5

The relationship between liver cyst volume and QOL in Japanese ADPKD patients

Muto, S; Ando, M; Nishio, S; Hanaoka, K; Ubara, Y; Narita, I; Kamura, K; Mochizuki, T; Tsuchiya, K; Tsuruya, K; Horie, S

CLINICAL AND EXPERIMENTAL NEPHROLOGY Vol. 24 ( 4 ) page： 314 - 322 2020.4

Efficacy and Safety of Rituximab in Refractory CIDP With or Without IgG4 Autoantibodies (RECIPE): Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial

Shimizu, S; Iijima, M; Fukami, Y; Tamura, N; Nakatochi, M; Ando, M; Nishi, R; Koike, H; Kaida, K; Koga, M; Kanda, T; Ogata, H; Kira, JI; Mori, M; Kuwabara, S; Katsuno, M

JMIR RESEARCH PROTOCOLS Vol. 9 ( 4 ) 2020.4

Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study

Okada, N; Iwama, S; Okuji, T; Kobayashi, T; Yasuda, Y; Wada, E; Onoue, T; Goto, M; Sugiyama, M; Tsunekawa, T; Takagi, H; Hagiwara, D; Ito, Y; Suga, H; Banno, R; Hase, T; Morise, M; Kanda, M; Yokota, K; Hashimoto, N; Ando, M; Fujimoto, Y; Nagino, M; Kodera, Y; Fujishiro, M; Hibi, H; Sone, M; Kiyoi, H; Gotoh, M; Ando, Y; Akiyama, M; Hasegawa, Y; Arima, H

BRITISH JOURNAL OF CANCER Vol. 122 ( 6 ) page： 771 - 777 2020.3

Patient-reported symptom burden as a prognostic factor in treatment with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial

Ooki, A; Morita, S; Iwamoto, S; Hara, H; Tanioka, H; Satake, H; Kataoka, M; Kotaka, M; Kagawa, Y; Nakamura, M; Shingai, T; Ishikawa, M; Miyake, Y; Suto, T; Hashiguchi, Y; Yabuno, T; Sakamoto, J; Tsuji, A; Ando, M; Yamaguchi, K

CANCER MEDICINE Vol. 9 ( 5 ) page： 1779 - 1789 2020.3

Survival Benefit of Maintained or Increased Body Mass Index in Patients Undergoing Extended-Hours Hemodialysis Without Dietary Restrictions

Hishida, M; Imaizumi, T; Nishiyama, T; Okazaki, M; Kaihan, AB; Kato, S; Kubo, Y; Ando, M; Kaneda, H; Maruyama, S

JOURNAL OF RENAL NUTRITION Vol. 30 ( 2 ) page： 154 - 162 2020.3

Development and validation of a driving simulator for evaluating the residual effects of drugs on driving performance - sensitivity analysis using zopiclone as a positive control Study Protocol Clinical Trial (SPIRIT Compliant)

Iwata, M; Iwamoto, K; Kambe, D; Tachibana, N; Ando, M; Ozaki, N

MEDICINE Vol. 99 ( 12 ) 2020.3

The impact of high-flow nasal cannula oxygen therapy on exercise capacity in fibrotic interstitial lung disease: a proof-of-concept randomized controlled crossover trial

Suzuki, A; Ando, M; Kimura, T; Kataoka, K; Yokoyama, T; Shiroshita, E; Kondoh, Y

BMC PULMONARY MEDICINE Vol. 20 ( 1 ) page： 51 2020.2

Yoshikawa, T; Ando, M; Mizusawa, J; Katai, H; Yamada, T; Ito, S; Fukagawa, T; Bando, E; Misawa, K; Katayama, H; Terashima, M; Sasako, M

JOURNAL OF CLINICAL ONCOLOGY Vol. 38 ( 4 ) 2020.2

　 PREV - NEXT 　

<ANDO, Masahiko>

Papers - ANDO, Masahiko